May National Provider Data Summary

May National Provider Data Summary

The following 2 Trusts did not submit any RTT pathway data:

  • Royal Free London NHS Foundation Trust (RAL)

  • Mid Essex Hospital Services NHS Trust (RQ8)

RTT Performance

As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to May 2018.




Waiting List Size

As the below graph demonstrates, from May 2018 to May 2019 the total waiting list size increased from 4,082,432 to 4,385,693, an increase of 303,261 (7.42%).



Below is a table showing each reporting Trusts variance in waiting list size from March 2019 to May 2019, sorted by percentage variance (please click to view the whole table).


52 Week Waiters

The below heatmap shows how the number of 52-week waiters has changed nationally, with areas such as the East Midlands and South managing to reduce their number of 52-week waiters.



Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2019 to May 2019, sorted by percentage variance (please click to view the whole table).



Changes to the Individual Specialties

In regard to the waiting list size of the individual specialties:


  • Cardiothoracic Surgery was the only speciality to see a decrease in the waiting list size, going from 8,892 to 8,436 a percentage decrease of 5.12%.

  • Geriatric Medicine saw the lowest increase in the waiting list size going from 20,244 to 20,261 an increase of 17 pathways.

  • Other and Ophthalmology both saw a high increase of the waiting list size with Other going from 911,666 to 928,657, an increase of 16,991 pathways (1.86%) and Ophthalmology going from 439,868 to 448,578, an increase of 8,710 pathways (1.98%).

  • Dermatology, as a single specialty saw the largest percentage increase in waiting list size, going from 203,375 to 213,524, a percentage increase of 4.99%.




Summary

  • At the end of May 2019, 86.9% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.

  • The number of RTT patients waiting to start treatment at the end of May 2019 was 4.4 million patients. Of those, 1,032 patients were waiting more than 52 weeks.

  • For patients waiting to start treatment at the end of May 2019, the median waiting time was 7.7 weeks. The 92nd percentile waiting time was 23.0 weeks.

  • During May 2019, 295,881 RTT patients started admitted treatment and 1,102,959 started non-admitted treatment (completed pathways).